Literature DB >> 16301479

Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy.

J Sone1, N Hishikawa, H Koike, N Hattori, M Hirayama, M Nagamatsu, M Yamamoto, F Tanaka, M Yoshida, Y Hashizume, H Imamura, E Yamada, G Sobue.   

Abstract

BACKGROUND: Neuronal intranuclear hyaline inclusion disease (NIHID), a rare neurodegenerative disease in which eosinophilic intranuclear inclusions develop mainly in neurons, has not yet been described to present as hereditary motor-sensory and autonomic neuropathy.
METHODS: Patients in two NIHID families showing peripheral neuropathy were evaluated clinically, electrophysiologically, and histopathologically.
RESULTS: In both families, patients had severe muscle atrophy and weakness in limbs, limb girdle, and face; sensory impairment in the distal limbs; dysphagia, episodic intestinal pseudoobstruction with vomiting attacks; and urinary and fecal incontinence. No patients developed symptoms suggesting CNS involvement. Electrophysiologic study showed the reduced motor and sensory nerve conduction velocities and amplitudes, and also extensive denervation potentials. In sural nerve specimens, numbers of myelinated and unmyelinated fibers were decreased. In two autopsy cases, eosinophilic intranuclear inclusions were widespread, particularly in sympathetic and myenteric ganglion neurons, dorsal root ganglion neurons, and spinal motor neurons. These neurons also were decreased in number.
CONCLUSION: Patients with neuronal intranuclear hyaline inclusion disease (NIHID) can manifest symptoms limited to those of peripheral neuropathy. NIHID therefore is part of the differential diagnosis of hereditary motor-sensory neuropathy associated with autonomic symptoms. Intranuclear hyaline inclusions in Schwann cells and in the myenteric plexus may permit antemortem diagnosis of NIHID.

Entities:  

Mesh:

Year:  2005        PMID: 16301479     DOI: 10.1212/01.wnl.0000184490.22527.90

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Neuronal Intranuclear Inclusion Disease: Longitudinal Case Report of Motor and Nonmotor Symptoms.

Authors:  Jennifer Vermilion; Mahlon Johnson; Jayasri Srinivasan; Jonathan W Mink
Journal:  J Child Neurol       Date:  2019-07-15       Impact factor: 1.987

Review 2.  Neuronal intranuclear inclusion disease: recognition and update.

Authors:  Xi Lu; Daojun Hong
Journal:  J Neural Transm (Vienna)       Date:  2021-02-18       Impact factor: 3.575

Review 3.  Neurodegenerative diseases associated with non-coding CGG tandem repeat expansions.

Authors:  Zhi-Dong Zhou; Joseph Jankovic; Tetsuo Ashizawa; Eng-King Tan
Journal:  Nat Rev Neurol       Date:  2022-01-12       Impact factor: 44.711

4.  Cognitive profiles in adult-onset neuronal intranuclear inclusion disease: a case series from the memory clinic.

Authors:  Fen Wang; Xiaowei Ma; Yuqing Shi; Longfei Jia; Xiumei Zuo; Yueyi Yu; Hongmei Jin; Yi Tang; Dongmei Guo; Jianping Jia
Journal:  Neurol Sci       Date:  2020-11-02       Impact factor: 3.307

5.  GGC repeat expansions in NOTCH2NLC causing a phenotype of distal motor neuropathy and myopathy.

Authors:  Jiaxi Yu; Xing-Hua Luan; Meng Yu; Wei Zhang; He Lv; Li Cao; Lingchao Meng; Min Zhu; Binbin Zhou; Xiao-Rong Wu; Pidong Li; Qiang Gang; Jing Liu; Xin Shi; Wei Liang; Zhirong Jia; Sheng Yao; Yun Yuan; Jianwen Deng; Daojun Hong; Zhaoxia Wang
Journal:  Ann Clin Transl Neurol       Date:  2021-05-04       Impact factor: 4.511

6.  Translation of GGC repeat expansions into a toxic polyglycine protein in NIID defines a novel class of human genetic disorders: The polyG diseases.

Authors:  Manon Boivin; Jianwen Deng; Véronique Pfister; Erwan Grandgirard; Mustapha Oulad-Abdelghani; Bastien Morlet; Frank Ruffenach; Luc Negroni; Pascale Koebel; Hugues Jacob; Fabrice Riet; Anke A Dijkstra; Kathryn McFadden; Wiley A Clayton; Daojun Hong; Hiroaki Miyahara; Yasushi Iwasaki; Jun Sone; Zhaoxia Wang; Nicolas Charlet-Berguerand
Journal:  Neuron       Date:  2021-04-21       Impact factor: 17.173

7.  Neuronal intranuclear inclusion disease presenting with resting tremor.

Authors:  Naoyuki Kitagawa; Jun Sone; Gen Sobue; Masahiko Kuroda; Michio Sakurai
Journal:  Case Rep Neurol       Date:  2014-05-28

8.  Clinicopathological features of adult-onset neuronal intranuclear inclusion disease.

Authors:  Jun Sone; Keiko Mori; Tomonori Inagaki; Ryu Katsumata; Shinnosuke Takagi; Satoshi Yokoi; Kunihiko Araki; Toshiyasu Kato; Tomohiko Nakamura; Haruki Koike; Hiroshi Takashima; Akihiro Hashiguchi; Yutaka Kohno; Takashi Kurashige; Masaru Kuriyama; Yoshihisa Takiyama; Mai Tsuchiya; Naoyuki Kitagawa; Michi Kawamoto; Hajime Yoshimura; Yutaka Suto; Hiroyuki Nakayasu; Naoko Uehara; Hiroshi Sugiyama; Makoto Takahashi; Norito Kokubun; Takuya Konno; Masahisa Katsuno; Fumiaki Tanaka; Yasushi Iwasaki; Mari Yoshida; Gen Sobue
Journal:  Brain       Date:  2016-10-25       Impact factor: 13.501

9.  Expansion of Human-Specific GGC Repeat in Neuronal Intranuclear Inclusion Disease-Related Disorders.

Authors:  Yun Tian; Jun-Ling Wang; Wen Huang; Sheng Zeng; Bin Jiao; Zhen Liu; Zhao Chen; Yujing Li; Ying Wang; Hao-Xuan Min; Xue-Jing Wang; Yong You; Ru-Xu Zhang; Xiao-Yu Chen; Fang Yi; Ya-Fang Zhou; Hong-Yu Long; Chao-Jun Zhou; Xuan Hou; Jun-Pu Wang; Bin Xie; Fan Liang; Zhuan-Yi Yang; Qi-Ying Sun; Emily G Allen; Andrew Mark Shafik; Ha Eun Kong; Ji-Feng Guo; Xin-Xiang Yan; Zheng-Mao Hu; Kun Xia; Hong Jiang; Hong-Wei Xu; Ran-Hui Duan; Peng Jin; Bei-Sha Tang; Lu Shen
Journal:  Am J Hum Genet       Date:  2019-06-06       Impact factor: 11.025

10.  Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case.

Authors:  Atsuhiko Sugiyama; Takahiro Takeda; Mizuho Koide; Hajime Yokota; Hiroki Mukai; Yoshihisa Kitayama; Kazumoto Shibuya; Nobuyuki Araki; Ai Ishikawa; Sagiri Isose; Kimiko Ito; Kazuhiro Honda; Yoshitaka Yamanaka; Terunori Sano; Yuko Saito; Kimihito Arai; Satoshi Kuwabara
Journal:  BMC Neurol       Date:  2021-07-09       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.